Correction to: novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.

Cell Biol Toxicol

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.

Published: August 2020

Unfortunately, there are some tiny errors in the data for Fig. 1a-c and Fig. 2a-e in the published online paper. Please see the correct relative data in Tables 3 and 4 given in the next page. These errors does not interfere the results and conclusions of authors study.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10565-020-09512-wDOI Listing

Publication Analysis

Top Keywords

correction novel
4
novel biphenyl
4
biphenyl diester
4
diester derivative
4
derivative ab-38b
4
ab-38b inhibits
4
inhibits nlrp3
4
nlrp3 inflammasome
4
inflammasome nrf2
4
nrf2 activation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!